Trefoil Therapeutics
Dr. Dhaliwal is a recognized expert in corneal and refractive surgery. She has authored several book chapters, numerous journal articles, and serves on the editorial board of several ophthalmology journals. In recognition of her clinical and surgical skills, she has been selected as a “Top Doctor” by her peers every year since 2006. Dr. Dhaliwal earned her medical degree from Northwestern University in the Honors Program in Medical Education where she was selected as a member of the Alpha Omega Alpha Honor Society.
This person is not in the org chart
This person is not in any offices
Trefoil Therapeutics
Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world.